People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions.
New Warning for Statins
Statins, including Pfizer Inc.’s Lipitor, are among the most prescribed drug in the world, and are currently routinely taken by millions of Americans. They are indicated for people with high blood pressure and/or high cholesterol, and have been shown to significantly reduce the risk of heart disease, heart attack, and stroke in this population. Yet the FDA has just issued new warnings concerning potential side effects: elevated blood sugar, which is a risk factor for developing type 2 diabetes, and cognitive impairment such as memory loss. The warnings will not be affixed to the outside of the bottle, but will be included in the package insert that comes with all prescription medications.